InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
17
T+90 hit rate
64%
T+90 mean return
+13.4%
Across 44 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Deschatelets Pascal, Chief Scientific Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 63 reports have been published. Breakdown: 0 buy · 17 sells. Total volume traded: €9.8m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 21 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations63 total
1,177,222 sharesCommon StockSEC:0001193125-26-224609
1,177,222 sharesCommon StockSEC:0001193125-26-224609:0
12,780 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-25-015285:0
826 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002377:0
3,948 shares@ US$30.42551.0% of flowCommon StockSEC:0001127602-25-001833:0
750 shares@ US$29.95820.2% of flowCommon StockSEC:0001127602-25-001618:0
15,045 shares0Common StockSEC:0001127602-25-001618:1
2,288 shares@ US$28.70210.5% of flowCommon StockSEC:0001127602-25-001189:0
24,500 shares@ US$3.760.7% of flowCommon StockSEC:0001127602-24-016107:0
78,907 shares@ US$4.312.7% of flowCommon StockSEC:0001127602-24-014811:0
69,107 shares@ US$3.762.0% of flowCommon StockSEC:0001127602-24-012710:0
64,379 shares@ US$54.116526.9% of flowCommon StockSEC:0001127602-24-012710:1
4,728 shares@ US$54.91522.0% of flowCommon StockSEC:0001127602-24-012710:2
69,107 shares@ US$3.671.9% of flowCommon StockSEC:0001127602-24-009368:0
1,148 shares@ US$67.76690.6% of flowCommon StockSEC:0001127602-24-004716:0
874 shares@ US$64.13820.4% of flowCommon StockSEC:0001127602-24-002736:0
3,913 shares@ US$64.9962.0% of flowCommon StockSEC:0001127602-24-001937:0
6,743 shares0Common StockSEC:0001127602-24-001443:0
45,000 shares@ US$3.761.3% of flowCommon StockSEC:0001127602-23-027431:0
17,494 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-027092:0
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-025708:0
12,000 shares@ US$40.383.8% of flowCommon StockSEC:0001127602-23-025708:1
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-023970:0
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-022231:0
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-020575:0
25 of 63 declarations
About Deschatelets Pascal
Pascal Deschatelets is the Chief Scientific Officer at Apellis Pharmaceuticals, Inc. In this role, he is responsible for the research and development of new treatments. His scientific expertise is essential for innovation and product development within Apellis.
